These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19456209)

  • 1. Novel application of lentiviral vectors towards treatment of graft-versus-host disease.
    Scaife MD; Neschadim A; Fowler DH; Medin JA
    Expert Opin Biol Ther; 2009 Jun; 9(6):749-61. PubMed ID: 19456209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
    Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
    Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function.
    Robinet E; Fehse B; Ebeling S; Sauce D; Ferrand C; Tiberghien P
    Cytotherapy; 2005; 7(2):150-7. PubMed ID: 16040394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide gene therapy and the control of graft-vs-host disease.
    Introna M; Rambaldi A
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):453-63. PubMed ID: 15498716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for acute graft-versus-host disease.
    Khaled Y; Reddy P; Krijanovski O
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease: emerging concepts in prevention and therapy.
    Dean RM; Bishop MR
    Curr Hematol Rep; 2003 Jul; 2(4):287-94. PubMed ID: 12901325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
    Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
    Har-Noy M; Slavin S
    Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Duran-Struuck R; Reddy P
    Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute graft-versus-host disease.
    Bacigalupo A
    Br J Haematol; 2007 Apr; 137(2):87-98. PubMed ID: 17391488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective depletion strategies in allogeneic stem cell transplantation.
    Mielke S; Solomon SR; Barrett AJ
    Cytotherapy; 2005; 7(2):109-15. PubMed ID: 16040390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.
    Alyea EP
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell therapy after hematopoietic stem cell transplantation.
    Kennedy-Nasser AA; Brenner MK
    Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host disease.
    Shlomchik WD
    Nat Rev Immunol; 2007 May; 7(5):340-52. PubMed ID: 17438575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
    Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.